Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study

Mockenhaupt, Maja; Viboud, Cecile; Dunant, Ariane; Naldi, Luigi; Halevy, Sima; Bouwes Bavinck, Jan Nico; Sidoroff, Alexis; Schneck, Jurgen; Roujeau, Jean-Claude; Flahault, Antoine

doi:10.1038/sj.jid.5701033

Article scientifique

Anglais

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study

Contributeurs/tricesMockenhaupt, Maja; Viboud, Cecile; Dunant, Ariane; Naldi, Luigi; Halevy, Sima; Bouwes Bavinck, Jan Nico; Sidoroff, Alexis; Schneck, Jurgen; Roujeau, Jean-Claude; Flahault, Antoine

Publié dansJournal of investigative dermatology, vol. 128, no. 1, p. 35-44

Date de publication2008

Mots-clés

Adrenal Cortex Hormones/adverse effects
Adult
Aged
Analgesics/adverse effects
Case-Control Studies
Humans
Middle Aged
Nevirapine/adverse effects
Risk
Sertraline/adverse effects
Stevens-Johnson Syndrome/*etiology
Time Factors
Triazines/adverse effects

Structure d'affiliation Pas une publication de l'UNIGE

Citation (format ISO)

MOCKENHAUPT, Maja et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. In: Journal of investigative dermatology, 2008, vol. 128, n° 1, p. 35–44. doi: 10.1038/sj.jid.5701033

Article (Published version)

Identifiants

PID : unige:47156
DOI : 10.1038/sj.jid.5701033
PMID : 17805350

ISSN du journal0022-202X

603vues

1téléchargements

Création23/02/2015 14:34:58

Première validation23/02/2015 14:34:58

Heure de mise à jour14/03/2023 22:54:25

Changement de statut14/03/2023 22:54:25

Dernière indexation16/01/2024 16:56:50

Archive ouverte UNIGE

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study

Informations techniques